The US Food and Drug Administration (FDA) has granted orphan drug designation (ODD) and rare paediatric disease designation (RPDD) to Arbor Biotechnologies' gene editing therapeutic, ABO-101, to treat ...
A clinical trial comparing a one-page medication handout proposed by the U.S. Food and Drug Administration (FDA) with an ...
The U.S. Food and Drug Administration has labeled the broccoli recall as a Class I, the highest risk level issued by the ...
Broccoli sold at Walmart in 20 states has been labeled potentially deadly in an update from the FDA. Was it sold in ...
The U.S. Food and Drug Administration approved a new non-opioid pain medication developed by the Massachusetts-based company ...
The FDA says millions of tons of food is wasted every year and now they want to better understand how you feel about ...
The FDA will allow two biotechnology companies to run clinical trials: United Therapeutics and eGenesis. United Therapeutics ...
(Scott Olson/Getty Images) In the final days of the Biden administration, the Food and Drug Administration proposed ... including the FDA and the Centers for Disease Control and Prevention ...
Robert Califf addressed a range of issues, including AI, lack of nutrition resources at the FDA and how he evaluates the progress of precision medicine at the Precision Medicine World Conference in ...
The Bridgewater, N.J., biopharmaceutical company said brensocatib has the potential to become the first and only approved treatment for non-cystic fibrosis bronchiectasis, which causes the lungs' ...
The U.S. Food and Drug Administration has approved Supernus Pharmaceuticals' drug-device combination to treat ...